Omicron variant: Move over, Delta
-
Very clever.
-
@jolly said in Move over, Delta:
Shocking...
Jolly, he is way off base. Novavax received emergency authorization for itās regular vaccine. They are now starting to research and develop an Omicron vaccine update. Moderna, J&J and the others are now talking about testing their standard vaccine against the variant, which makes sense.
-
@george-k said in Move over, Delta:
The "already worried" tweet was on Aug 4.
Hey, I'm still holding out hope for my Omega Variant prediction from Aug 2: https://nodebb.the-new-coffee-room.club/topic/10582/what-s-the-next-best-outbreak-name
-
You completely miss the point in true Axian manner. No one said Trump's bans were great or effective. But Biden slammed them as racist and now imposes his own.
-
Moderna CEO expects material drop in Moderna vaccineās effectiveness against the Omicron variant.
-
Moderna CEO expects material drop in Moderna vaccineās effectiveness against the Omicron variant.
@axtremus said in Move over, Delta:
Moderna CEO expects material drop in Moderna vaccineās effectiveness against the Omicron variant.
At this point in time, he's blowing smoke out of his ass.
-
Moderna CEO expects material drop in Moderna vaccineās effectiveness against the Omicron variant.
-
@George-K Reminds me of @bachophile post about spread vs seriousness of diseaseā¦ This may be less serious on average, but if itās spread is wider it could be far worse than Delta.
-
@Jolly I would think that they could look at the particular spike proteins their particular vaccine targets and be able to say āoh
ā -
Dr. UÄur Åahināthe co-founder of BioNTech who helped develop Pfizerās mRNA COVID-19 vaccineātold The Wall Street Journal Tuesday that, even if the Omicron variant leads to more breakthrough COVID-19 infections, he believes the vaccines will continue to protect against severe disease. āIf a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe diseaseāthe T-cells,ā he said.
The European Centre for Disease Prevention and Control said yesterday that as of Tuesday morning, 44 Omicron variant cases had been confirmed by 11 European countries and that āall cases for which there is information available on severity were either asymptomatic or had mild symptoms.ā
-
Dr. UÄur Åahināthe co-founder of BioNTech who helped develop Pfizerās mRNA COVID-19 vaccineātold The Wall Street Journal Tuesday that, even if the Omicron variant leads to more breakthrough COVID-19 infections, he believes the vaccines will continue to protect against severe disease. āIf a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe diseaseāthe T-cells,ā he said.
The European Centre for Disease Prevention and Control said yesterday that as of Tuesday morning, 44 Omicron variant cases had been confirmed by 11 European countries and that āall cases for which there is information available on severity were either asymptomatic or had mild symptoms.ā
@jon-nyc said in Move over, Delta:
Dr. UÄur Åahināthe co-founder of BioNTech who helped develop Pfizerās mRNA COVID-19 vaccineātold The Wall Street Journal Tuesday that, even if the Omicron variant leads to more breakthrough COVID-19 infections, he believes the vaccines will continue to protect against severe disease. āIf a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe diseaseāthe T-cells,ā he said.
IOW, he believes the Nu variant of Wuhan COVID -Xi 19 achieves immune escape against the current virus but they are hoping that the T-Cells will save the day. The question I have is if the T-Cells are working on the same recognition patterns as the antibodies, why do they think it will work? The ID of the spike proteins had to be very specific as there are necessary and beneficial spike proteins that you do not want to mess with. Itās a big part of the concern with the Merck pill. They have seen examples of stillborn and birth defects when administered to pregnant animals.
https://www.latimes.com/science/story/2021-11-29/fda-merck-covid-pill-effective-but-flags-safety-concerns-pregnant-womenThe Brad
-
@jon-nyc said in Move over, Delta:
The European Centre for Disease Prevention and Control said yesterday that as of Tuesday morning, 44 Omicron variant cases had been confirmed by 11 European countries and that āall cases for which there is information available on severity were either asymptomatic or had mild symptoms.ā
That would be the same number with Delta or even Alpha.
-
@jon-nyc said in Move over, Delta:
Dr. UÄur Åahināthe co-founder of BioNTech who helped develop Pfizerās mRNA COVID-19 vaccineātold The Wall Street Journal Tuesday that, even if the Omicron variant leads to more breakthrough COVID-19 infections, he believes the vaccines will continue to protect against severe disease. āIf a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe diseaseāthe T-cells,ā he said.
IOW, he believes the Nu variant of Wuhan COVID -Xi 19 achieves immune escape against the current virus but they are hoping that the T-Cells will save the day. The question I have is if the T-Cells are working on the same recognition patterns as the antibodies, why do they think it will work? The ID of the spike proteins had to be very specific as there are necessary and beneficial spike proteins that you do not want to mess with. Itās a big part of the concern with the Merck pill. They have seen examples of stillborn and birth defects when administered to pregnant animals.
https://www.latimes.com/science/story/2021-11-29/fda-merck-covid-pill-effective-but-flags-safety-concerns-pregnant-women@lufins-dad said in Move over, Delta:
@jon-nyc said in Move over, Delta:
Dr. UÄur Åahināthe co-founder of BioNTech who helped develop Pfizerās mRNA COVID-19 vaccineātold The Wall Street Journal Tuesday that, even if the Omicron variant leads to more breakthrough COVID-19 infections, he believes the vaccines will continue to protect against severe disease. āIf a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe diseaseāthe T-cells,ā he said.
IOW, he believes the Nu variant of Wuhan COVID -Xi 19 achieves immune escape against the current virus but they are hoping that the T-Cells will save the day. The question I have is if the T-Cells are working on the same recognition patterns as the antibodies, why do they think it will work? The ID of the spike proteins had to be very specific as there are necessary and beneficial spike proteins that you do not want to mess with. Itās a big part of the concern with the Merck pill. They have seen examples of stillborn and birth defects when administered to pregnant animals.
https://www.latimes.com/science/story/2021-11-29/fda-merck-covid-pill-effective-but-flags-safety-concerns-pregnant-womenLast study I saw, T-cells had at least eight months response. I suspect it's more.
